What are the recent financial highlights of SUPRIYA LIFESCIENCE LTD?

SUPRIYA LIFESCIENCE LTD recently reported a total revenue of ₹670.56 Cr and a net profit margin of 26.02%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of SUPRIYA LIFESCIENCE LTD?

SUPRIYA LIFESCIENCE LTD offers a dividend yield of 0.11%, with a dividend rate of ₹0.8 per share.

What are the key financial metrics of SUPRIYA LIFESCIENCE LTD?

Key financial metrics include a trailing P/E ratio of 30.006931, forward P/E of 28.859999, book value of ₹112.085, price-to-book ratio of 5.7933707, and a market capitalization of ₹52.38 billion.

What does SUPRIYA LIFESCIENCE LTD do?

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antihypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Supriya

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Supriya

Latest updates related to Supriya

Sr No.	Title	Sentiment
1	Supriya Lifescience Reports Strong Growth Amid Challenging Market Conditions MarketsMojo	🔄
2	'You have a wife and a child' – Supriya Menon's playful reminder to Prithviraj TOI Etimes	🔄
3	‘Supriya ki aankhein dekho, kitni achchi hai’: Ratna Pathak Shah on building self-confidence despite measuring her looks against sister’s The Indian Express	🔄
4	Breaking Barriers: Supriya Mankame’s Impact in the Tech Industry Digital Terminal	🔄
5	Supriya Sule urges CM Fadnavis to expedite probes into Beed, Parbhani crimes The Hindu	🔄
6	Supriya Newar’s collection of Hindustani poetry, ‘Justaju’, reflects her own literary quest Telegraph India	🔄
7	Supriya Pathak And Daughter Sanah Kapur Recreate Viral Hansa-Maya Sarabhai Reel, But There’s A Twist \| Watc News18	🔄
8	"Need It At Super Speed": Supriya Sule As Injured Student's Father Waits For US Visa NDTV	🔄
9	Supriya Lifescience share price soars 7% in weak market today; here's why Business Standard	🔄
10	From adversity to achievement: Supriya Das pioneers mechanized seeding and women’s empowerment in Odisha CGIAR	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

MANDEEP PURPLEUTED LATENTVIEW AHIMSA RAMCOIND INOXWIND DISHTV ORIANA SHRITECH SANOFICONR